Immune Design Corp. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
30,387.00
75,354.00
112,921.00
107,255.00
147,107.00
Total Accounts Receivable
87.00
1,970.00
972.00
3,673.00
3,781.00
Inventories
17.00
25.00
13.00
607.00
684.00
Other Current Assets
179.00
633.00
1,654.00
2,546.00
1,571.00
Total Current Assets
30,670.00
77,982.00
115,560.00
114,081.00
153,143.00
Net Property, Plant & Equipment
295.00
401.00
585.00
414.00
491.00
Other Assets
-
-
-
-
200.00
Total Assets
30,965.00
78,383.00
116,145.00
114,495.00
153,834.00
Accounts Payable
866.00
6,903.00
3,074.00
4,559.00
2,334.00
Other Current Liabilities
1,109.00
5,044.00
4,037.00
14,704.00
12,186.00
Total Current Liabilities
1,975.00
11,947.00
7,111.00
19,263.00
14,520.00
Other Liabilities
3,430.00
90.00
41.00
56.00
102.00
Total Liabilities
5,405.00
12,037.00
7,152.00
19,319.00
14,622.00
Common Equity (Total)
55,834.00
66,346.00
108,993.00
95,176.00
139,212.00
Total Shareholders' Equity
25,560.00
66,346.00
108,993.00
95,176.00
139,212.00
Total Equity
25,560.00
66,346.00
108,993.00
95,176.00
139,212.00
Liabilities & Shareholders' Equity
30,965.00
78,383.00
116,145.00
114,495.00
153,834.00
Preferred Stock (Carrying Value)
81,394.00
-
-
-
-
About Immune Design
View Profile
